Aspen Aerogels price target raised to $7.75 from $5.75 at Roth Capital
upside_potential
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
upside_potential
What happened, with direct paths to the underlying reporting
Roth Capital raises ASPN target to $7.75 from $5.75. Current price is $5.90; potential upside remains.
Target: $7.75
Posted price: $5.9
Analyst firm: Roth Capital
Analyst: Chip Moore
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.